Core Laboratories Inc reports results for the quarter ended in January 1 - Earnings Summary

• Core Laboratories Inc CLB.N reported quarterly adjusted earnings of 25 cents​​ per share for the quarter ended January 1, higher than the same quarter last year, when the company reported EPS of 22 cents. The mean expectation of seven analysts for the quarter was for earnings of 23 cents per share. Wall Street expected results to range from 17 cents to 26 cents per share.

• Revenue rose 7.2% to $134.40 million from a year ago; analysts expected $134.04 million.

• Core Laboratories Inc's reported EPS for the quarter was 25 cents​.

• The company reported quarterly net income of $11.75 million.

• Core Laboratories Inc shares had fallen by 6.9% this quarter and lost 2.3% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 5.6% in the last three months.​

• In the last 30 days, two analysts negatively revised earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 5 "hold" and 2 "sell" or "strong sell."

• The average consensus recommendation for the business support services peer group is also "hold"

Wall Street's median 12-month price target for Core Laboratories Inc is 18.00

This summary was machine generated from LSEG data October 24 at 03:00 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)